G-286. FEATURES OF THE MECHANISM OF  DEVELOPMENT OF PULMONARY HYPERTENSION IN  PATIENTS UNDERGOING HEMODIALYSIS THROUGH  ARTERIOVENOUS ACCESS

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/5647

Title:	G-286. FEATURES OF THE MECHANISM OF DEVELOPMENT OF PULMONARY HYPERTENSION IN PATIENTS UNDERGOING HEMODIALYSIS THROUGH ARTERIOVENOUS ACCESS
Authors:	Asal Abduvakhitova1, 2, Durdona Saipova2.
Issue Date:	9-Apr-2025
Publisher:	AJKD AMERICAN JOURNAL OF KIDNEY DISEASES
Abstract:	Pulmonary hypertension (PH) is a significant complication in ESRD patients on HD, exacerbated by AV fistulas and involving dysregulation of endothelin-1 (ET-1) and nitric oxide (NO). Aim to evaluate the role of endothelin-1 (ET-1) and nitric oxide (NO) in the development and progression of PH in patients on program hemodialysis and with AV access
URI:	http://repo.tma.uz/xmlui/handle/1/5647
Appears in Collections:

Files in This Item:

File	Description	Size	Format
NATIONAL_KIDNEY_FOUNDATION_2025_SPRING_CLINICAL_MEETING_ABSTRACTS (4).pdf		399.41 kB	Adobe PDF	View/Open

DSpace JSPUI